Status
Conditions
Treatments
About
The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.
Enrollment
Sex
Volunteers
Inclusion criteria
1.Patients with symptoms such as abdominal pain, black stools, constipation, or diarrhea undergo colonoscopy for diagnostic purposes.
Exclusion criteria
1,200 participants in 3 patient groups
Loading...
Central trial contact
Li mian Er, doctor; Zhenzhen Wang, master
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal